Island-based technology company, Innovative Physics, has joined forces with academics and healthcare experts to help progress innovations in cancer detection technology.
Innovative Physics, based in Shanklin on the Isle of Wight, has joined University of Portsmouth’s SIGHT (Supporting Innovation and Growth in Healthcare Technologies) programme, which aims to bring experts together to enhance the development of ground-breaking healthcare technologies.
Innovative Physics is known for its pioneering technology using pattern recognition and Artificial Intelligence to help detect, identify, and grade radioactive material in the nuclear sector. They have also gained recognition for the use of their technology in other markets, such as homeland security, waste, and agriculture.
The company is also seeking to develop technology that can be used as a medical diagnostic tool, with early clinical trials for lung cancer returning results in minutes.
Dr Phil Jewell, SIGHT business development and programme manager, said: “Innovative Physics have some extremely interesting technologies which could prove invaluable in the early detection and management of cancer and our hope is that, through this programme, we can help them fast-track their products and technologies to market and deliver those benefits to many people.”
Victoria Anderson-Matthew, Business Development Officer at Innovative Physics, said: “The application of artificial intelligence has endless possibilities in both trials and in clinical diagnosis. We are confident that our technologies can help make significant inroads in the healthcare sector but, as a relatively small business, it is difficult to overcome the barriers to entering these markets which are often dominated by large multinationals. We hope, through our link with SIGHT, that we can make a breakthrough into the healthcare sector and realise our ambitions of bringing our potentially ground-breaking technologies to the marketplace.”
Mike Anderson, Chief Executive Officer of Innovative Physics, who was himself diagnosed with prostate cancer a few years ago, said: “With one in every two people being diagnosed with cancer in their lifetime, now more than ever being able to spot cancer early and save lives is vitally important. My hope is that the tools we have developed will do just that.”